CordenPharma is the CDMO partner you need for small to large-scale peptide development and manufacturing. As a result of increasing demand in the GLP-1 medications market, our recently announced peptide initiatives include significant expansions in CordenPharma Colorado (US) and a new greenfield site to be constructed in Switzerland, both designed according to the pharmaceutical industry’s most stringent quality and technical standards for short and long peptide manufacturing, including BLA requirements.
With a passionate team of scientific experts, we leverage decades of experience in providing innovators with complex modalities across our Peptide, Oligonucleotide, and Lipids platforms, seamlessly integrated with bespoke LNP formulation and Injectable manufacturing to secure your supply chain at any scale. https://cordenpharma.com/